Association between serum uric acid levels and left ventricular hypertrophy based on electrocardiographic findings: a sex-specific analysis across cardiometabolic diseases

Abstract The association between serum uric acid (UA) levels and left ventricular hypertrophy (LVH) remains unclear. We aimed to investigate this association using electrocardiographic findings. Health examination data from Kagoshima Kouseiren Hospital included 79,200 participants without cardiovasc...

Full description

Saved in:
Bibliographic Details
Main Authors: Anwar Ahmed Salim, Shin Kawasoe, Takuro Kubozono, Satoko Ojima, Satoshi Yamaguchi, Koji Higuchi, Yoshiyuki Ikeda, Hironori Miyahara, Koichi Tokushige, Mitsuru Ohishi
Format: Article
Language:English
Published: Nature Portfolio 2025-01-01
Series:Scientific Reports
Subjects:
Online Access:https://doi.org/10.1038/s41598-025-86497-8
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832585805520961536
author Anwar Ahmed Salim
Shin Kawasoe
Takuro Kubozono
Satoko Ojima
Satoshi Yamaguchi
Koji Higuchi
Yoshiyuki Ikeda
Hironori Miyahara
Koichi Tokushige
Mitsuru Ohishi
author_facet Anwar Ahmed Salim
Shin Kawasoe
Takuro Kubozono
Satoko Ojima
Satoshi Yamaguchi
Koji Higuchi
Yoshiyuki Ikeda
Hironori Miyahara
Koichi Tokushige
Mitsuru Ohishi
author_sort Anwar Ahmed Salim
collection DOAJ
description Abstract The association between serum uric acid (UA) levels and left ventricular hypertrophy (LVH) remains unclear. We aimed to investigate this association using electrocardiographic findings. Health examination data from Kagoshima Kouseiren Hospital included 79,200 participants without cardiovascular diseases. Hypertension was defined as a blood pressure ≥ 140/90 mmHg. A Sokolow–Lyon criterion of ≥ 3.5 mm was used to define LVH. Sex-specific associations between UA and LVH were adjusted for age, body mass index, systolic blood pressure, serum triglyceride, low-density lipoprotein cholesterol, high-density lipoprotein cholesterol, fasting plasma glucose, estimated glomerular filtration rate, and lifestyle factors. The mean UA levels were 4.5 ± 1.1 and 6.1 ± 1.4 mg/dL in women and men, respectively (LVH prevalences, 4.0%, and 11.8%, respectively). Individuals without and with hypertension had mean UA levels of 5.2 ± 1.4 and 5.7 ± 1.5 mg/dL, respectively (LVH prevalences, 5.5%, and 14.4%, respectively). UA levels were significantly associated with LVH in women aged 40–49 and 50–59 years and in men aged 50–59 years. Compared with the first UA quartile, the fourth quartile showed a more significant association with LVH in individuals without hypertension. Furthermore, UA was associated with LVH in individuals without obesity, dyslipidemia, reduced kidney function, and diabetes in both sexes. Serum UA levels are associated with LVH in middle-aged women and men without cardiovascular disease risk, suggesting the potential role of UA as an LVH marker. Anwar Ahmed Salim and Shin Kawasoe contributed equally to this work.
format Article
id doaj-art-cf61d220dc4c42a597e40c91b29b5d9f
institution Kabale University
issn 2045-2322
language English
publishDate 2025-01-01
publisher Nature Portfolio
record_format Article
series Scientific Reports
spelling doaj-art-cf61d220dc4c42a597e40c91b29b5d9f2025-01-26T12:31:05ZengNature PortfolioScientific Reports2045-23222025-01-0115111210.1038/s41598-025-86497-8Association between serum uric acid levels and left ventricular hypertrophy based on electrocardiographic findings: a sex-specific analysis across cardiometabolic diseasesAnwar Ahmed Salim0Shin Kawasoe1Takuro Kubozono2Satoko Ojima3Satoshi Yamaguchi4Koji Higuchi5Yoshiyuki Ikeda6Hironori Miyahara7Koichi Tokushige8Mitsuru Ohishi9Department of Cardiovascular Medicine and Hypertension, Graduate School of Medical and Dental Sciences, Kagoshima UniversityDepartment of Cardiovascular Medicine and Hypertension, Graduate School of Medical and Dental Sciences, Kagoshima UniversityDepartment of Cardiovascular Medicine and Hypertension, Graduate School of Medical and Dental Sciences, Kagoshima UniversityDepartment of Cardiovascular Medicine and Hypertension, Graduate School of Medical and Dental Sciences, Kagoshima UniversityDepartment of Cardiovascular Medicine and Hypertension, Graduate School of Medical and Dental Sciences, Kagoshima UniversityDepartment of Cardiovascular Medicine and Hypertension, Graduate School of Medical and Dental Sciences, Kagoshima UniversityDepartment of Cardiovascular Medicine and Hypertension, Graduate School of Medical and Dental Sciences, Kagoshima UniversityKagoshima Kouseiren HospitalKagoshima Kouseiren HospitalDepartment of Cardiovascular Medicine and Hypertension, Graduate School of Medical and Dental Sciences, Kagoshima UniversityAbstract The association between serum uric acid (UA) levels and left ventricular hypertrophy (LVH) remains unclear. We aimed to investigate this association using electrocardiographic findings. Health examination data from Kagoshima Kouseiren Hospital included 79,200 participants without cardiovascular diseases. Hypertension was defined as a blood pressure ≥ 140/90 mmHg. A Sokolow–Lyon criterion of ≥ 3.5 mm was used to define LVH. Sex-specific associations between UA and LVH were adjusted for age, body mass index, systolic blood pressure, serum triglyceride, low-density lipoprotein cholesterol, high-density lipoprotein cholesterol, fasting plasma glucose, estimated glomerular filtration rate, and lifestyle factors. The mean UA levels were 4.5 ± 1.1 and 6.1 ± 1.4 mg/dL in women and men, respectively (LVH prevalences, 4.0%, and 11.8%, respectively). Individuals without and with hypertension had mean UA levels of 5.2 ± 1.4 and 5.7 ± 1.5 mg/dL, respectively (LVH prevalences, 5.5%, and 14.4%, respectively). UA levels were significantly associated with LVH in women aged 40–49 and 50–59 years and in men aged 50–59 years. Compared with the first UA quartile, the fourth quartile showed a more significant association with LVH in individuals without hypertension. Furthermore, UA was associated with LVH in individuals without obesity, dyslipidemia, reduced kidney function, and diabetes in both sexes. Serum UA levels are associated with LVH in middle-aged women and men without cardiovascular disease risk, suggesting the potential role of UA as an LVH marker. Anwar Ahmed Salim and Shin Kawasoe contributed equally to this work.https://doi.org/10.1038/s41598-025-86497-8Serum uric acidLeft ventricular hypertrophyElectrocardiographic findingsCardiometabolic diseases
spellingShingle Anwar Ahmed Salim
Shin Kawasoe
Takuro Kubozono
Satoko Ojima
Satoshi Yamaguchi
Koji Higuchi
Yoshiyuki Ikeda
Hironori Miyahara
Koichi Tokushige
Mitsuru Ohishi
Association between serum uric acid levels and left ventricular hypertrophy based on electrocardiographic findings: a sex-specific analysis across cardiometabolic diseases
Scientific Reports
Serum uric acid
Left ventricular hypertrophy
Electrocardiographic findings
Cardiometabolic diseases
title Association between serum uric acid levels and left ventricular hypertrophy based on electrocardiographic findings: a sex-specific analysis across cardiometabolic diseases
title_full Association between serum uric acid levels and left ventricular hypertrophy based on electrocardiographic findings: a sex-specific analysis across cardiometabolic diseases
title_fullStr Association between serum uric acid levels and left ventricular hypertrophy based on electrocardiographic findings: a sex-specific analysis across cardiometabolic diseases
title_full_unstemmed Association between serum uric acid levels and left ventricular hypertrophy based on electrocardiographic findings: a sex-specific analysis across cardiometabolic diseases
title_short Association between serum uric acid levels and left ventricular hypertrophy based on electrocardiographic findings: a sex-specific analysis across cardiometabolic diseases
title_sort association between serum uric acid levels and left ventricular hypertrophy based on electrocardiographic findings a sex specific analysis across cardiometabolic diseases
topic Serum uric acid
Left ventricular hypertrophy
Electrocardiographic findings
Cardiometabolic diseases
url https://doi.org/10.1038/s41598-025-86497-8
work_keys_str_mv AT anwarahmedsalim associationbetweenserumuricacidlevelsandleftventricularhypertrophybasedonelectrocardiographicfindingsasexspecificanalysisacrosscardiometabolicdiseases
AT shinkawasoe associationbetweenserumuricacidlevelsandleftventricularhypertrophybasedonelectrocardiographicfindingsasexspecificanalysisacrosscardiometabolicdiseases
AT takurokubozono associationbetweenserumuricacidlevelsandleftventricularhypertrophybasedonelectrocardiographicfindingsasexspecificanalysisacrosscardiometabolicdiseases
AT satokoojima associationbetweenserumuricacidlevelsandleftventricularhypertrophybasedonelectrocardiographicfindingsasexspecificanalysisacrosscardiometabolicdiseases
AT satoshiyamaguchi associationbetweenserumuricacidlevelsandleftventricularhypertrophybasedonelectrocardiographicfindingsasexspecificanalysisacrosscardiometabolicdiseases
AT kojihiguchi associationbetweenserumuricacidlevelsandleftventricularhypertrophybasedonelectrocardiographicfindingsasexspecificanalysisacrosscardiometabolicdiseases
AT yoshiyukiikeda associationbetweenserumuricacidlevelsandleftventricularhypertrophybasedonelectrocardiographicfindingsasexspecificanalysisacrosscardiometabolicdiseases
AT hironorimiyahara associationbetweenserumuricacidlevelsandleftventricularhypertrophybasedonelectrocardiographicfindingsasexspecificanalysisacrosscardiometabolicdiseases
AT koichitokushige associationbetweenserumuricacidlevelsandleftventricularhypertrophybasedonelectrocardiographicfindingsasexspecificanalysisacrosscardiometabolicdiseases
AT mitsuruohishi associationbetweenserumuricacidlevelsandleftventricularhypertrophybasedonelectrocardiographicfindingsasexspecificanalysisacrosscardiometabolicdiseases